MDXG

MiMedx Group, Inc.

About MDXG

MiMedx Group, Inc. is a transformational placental biologics company, developing and distributing placental tissue allografts for multiple sectors of healthcare. The Company is focused on addressing unmet clinical needs in the areas of advanced wound care, surgical recovery applications, and musculoskeletal conditions. The Company’s primary platform technologies include EPIFIX, AMNIOFIX, EPICORD, and AMNIOCORD. The AMNIOFIX and EPIFIX are its tissue allografts derived from the amnion and chorion layers of the human placental membrane. Its EPICORD and AMNIOCORD are tissue allografts derived from umbilical cord tissue. EPIFIX is a semi-permeable, protective barrier allograft comprised of dehydrated human amnion/chorion membrane that may be used in the treatment of chronic wounds, including diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), and pressure ulcers. AMNIOFIX is used in surgical recovery applications including in the areas of spine, orthopedic, sports medicine and urologic.

Buy US stocks in Australia starting with MDXG. Open an account and start investing today!

Market Capitalisation

$403.85M

Price-earnings ratio

Dividend yield

0.00%

Volume

961.89K

High today

$3.52

Low today

$3.11

Open price

$3.46

52-week high

$5.06

52-week low

$2.43

MDXG FAQs

How much is one share of MiMedx Group, Inc.?

One share of MiMedx Group, Inc. is valued at $3.37.

What is the ticker symbol for MiMedx Group, Inc.?

The ticker symbol for MiMedx Group, Inc. is MDXG.

How do I buy MDXG shares in Australia?

To buy MDXG stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in MDXG

What is the 52-week high for MiMedx Group, Inc. stock?

The MiMedx Group, Inc. 52-week high stock price is $5.06.

What is the 52-week low for MiMedx Group, Inc. stock?

The MiMedx Group, Inc. 52-week low stock price is $2.43.

What is the market capitalisation of MiMedx Group, Inc. MDXG?

As of 25/03/2023 MiMedx Group, Inc. has a market cap of $404M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.